Originally published In Press as doi:10.1074/jbc.M007594200 on September 5, 2000
J. Biol. Chem., Vol. 275, Issue 48, 37951-37956, December 1, 2000
In Vivo and in Vitro Function of GroEL
Mutants with Impaired Allosteric Properties*
Yael
Fridmann
,
Shimon
Ulitzur§, and
Amnon
Horovitz
¶
From the
Department of Structural Biology, Weizmann
Institute of Science, Rehovot 76100 and the § Department of
Food Engineering and Biotechnology, Technion, Haifa 32000, Israel
Received for publication, August 21, 2000
 |
ABSTRACT |
Escherichia coli cells that produce
only plasmid-encoded wild-type or mutant GroEL were generated by
bacteriophage P1 transduction. Effects of mutations that affect the
allosteric properties of GroEL were characterized in vivo.
Cells containing only GroEL(R197A), which has reduced intra-ring
positive cooperativity and inter-ring negative cooperativity in ATP
binding, grow poorly upon a temperature shift from 25 to 42 °C. This
strain supports the growth of phages T4 and T5 but not phage
and
produces light at 28 °C when transformed with a second plasmid
containing the lux operon. In contrast, cells containing
only GroEL(R13G, A126V) which lacks negative cooperativity between
rings but has intact intra-ring positive cooperativity grow normally
and support phage growth but do not produce light at 28 °C. In
vitro refolding of luciferase in the presence of this mutant is
found to be less efficient compared with wild-type GroEL or other
mutants tested. Our results show that allostery in GroEL is important
in vivo in a manner that depends on the physiological
conditions and is protein substrate specific.
 |
INTRODUCTION |
The Escherichia coli GroE system facilitates protein
folding in vivo and in vitro in an
ATP-dependent manner (for recent reviews see, for example,
Refs. 1-4). It is composed of GroEL, an oligomer of 14 identical
subunits that form two heptameric rings, stacked back-to-back, with
7-fold symmetry and a cavity at each end (5), and its helper-protein
GroES which is a seven-membered ring of identical subunits (6). GroEL
has 14 ATP-binding sites and a weak
K+-dependent (7) ATPase activity. It undergoes
ATP-induced conformational changes (8) that are reflected in binding of
ATP with intra-ring positive cooperativity (9-11) and inter-ring
negative cooperativity (12, 13).
Coupling between protein folding and allostery in the GroE system has
recently been demonstrated in vitro (14). The importance of
the allosteric properties of GroEL for its function in vivo remains, however, unclear. It has been questioned due to (i) the fact
that the allosteric transitions of GroEL take place in vitro at subphysiological (micromolar) concentrations of ATP (13), and (ii)
the finding that the apical domain of GroEL, which is devoid of ATPase
activity, is active in vivo (15). More recently, it has been
demonstrated that the oligomeric structure of GroEL is required for
biological activity because of the need for an intact cavity (16, 17).
Evidence for the importance of the oligomeric structure of GroEL for
activity in vivo owing to the requirement for proper
allosteric communication within and between rings has, however, not
been reported. We decided to begin addressing this issue by generating
E. coli strains that express only plasmid-derived GroEL
which is either wild type (as a control) or mutant with modified
allosteric properties. The following GroEL mutants with different
altered allosteric properties were chosen for analysis as follows: (i)
GroEL(K4E) with disrupted inter-subunit contacts (18, 19); (ii)
GroEL(R13G, A126V) with intact positive cooperativity and disrupted
negative cooperativity (20); (iii) GroEL(R197A) with strongly
diminished positive cooperativity and weakened negative cooperativity
(12); (iv) GroEL(E409A, R501A) with increased positive and slightly
weakened negative cooperativity (21), and (v) GroEL(R501A) with
weakened positive cooperativity and disrupted negative cooperativity
(21). To date, there have been very few studies on the in
vivo consequences of mutations in GroEL known to modify its
properties in vitro (see, for example, Ref. 22). Herein, we
show that such mutations affect the function of GroEL in
vivo (in cells that lack background chromosomal wild-type GroEL)
and demonstrate that the effects depend on the physiological conditions
and are protein substrate-specific.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Molecular biology reagents were purchased from
Roche Molecular Biochemicals unless otherwise stated. The synthetic
autoinducer N-(3-oxyhexanoyl) homoserine lactone was kindly
provided by A. Eberhard, Ithaca College, NY. All other reagents were
obtained from Sigma or Aldrich. GroEL and GroES were purified as
described (23).
Subcloning--
The groEL gene was amplified from the
pOA plasmid (24) using Pwo DNA polymerase and the following
oligonucleotides: FOR, 5'-GCG AAT
TCA TCC GCG CAC GAC ACT G-3'; BACK, 5'-TGT AAA ACG ACG GCC
AGT-3'. The FOR oligonucleotide is complementary to the region between
GroEL and GroES except for the first 8 nucleotides that contain an
EcoRI restriction site (underlined). The BACK oligonucleotide is complementary to the region of the plasmid flanking
the 3' end of the gene. The reactions were carried out using Pwo DNA
polymerase in 10 mM Tris-HCl buffer (pH 8.85 at 20 °C)
containing 25 mM KCl, 5 mM
(NH4)2SO4, 2 mM
MgSO4, 0.8 mM of each dNTP, 140 pmol of each
primer, and 0.5 µg of template DNA (containing the wild-type or
mutant groEL gene). The
PCR1 cycle consisted of 3 min
at 94 °C followed by 30 cycles of 1 min at 94 °C, 1 min at
58 °C, and 2 min at 72 °C and, finally, 10 additional min at
72 °C. The 1.8-kilobase pair PCR products that contained the
groEL gene were purified, digested by HindIII and
EcoRI, heated for 5 min at 45 °C, repurified, and ligated overnight on ice to the plasmid pBAD30 (25) which was previously digested with the same enzymes. The groEL genes subcloned
into the pBAD vector were fully sequenced. The pBAD vector contains the
arabinose PBAD promoter which is induced by
L-arabinose and repressed by glucose. This vector confers
ampicillin resistance and has a pACYC184 (P15A) origin of replication.
It is designated pBADEL(mutant type).
A 12-kilobase pair SalI restriction fragment of the plasmid
pBTK5 (26) containing the complete lux operon of
Vibrio fischeri (27) was subcloned into pALTER-1
(Promega) previously digested with the same enzyme. This vector confers
tetracycline resistance and has a ColE1 origin of replication that is
compatible with the pBADEL vectors.
Creation of E. coli Strains with a Deletion of the Chromosomal
groEL Gene--
The chromosomal groEL gene of E. coli TG1 cells containing pBADEL(mutant type) was replaced with
the nptII gene that confers kanamycin resistance by P1
transduction using AI90/pBADEL as a donor strain (28). The AI90/pBADEL
strain is able to grow because the plasmid pBADEL expresses wild-type
GroEL under control of the arabinose promoter (25). The transduction
was performed by adding 0.1 ml of P1 phage (109 pfu/ml) to
0.1 ml of TG1/pBADEL(mutant type) cells that were grown overnight in 5 ml of LB medium containing 50 µg/ml ampicillin and then spun down in
a microcentrifuge (6000 rpm for 10 min), resuspended in 5 ml of 0.1 M MgSO4 and 5 mM CaCl2,
and gently shaken at 37 °C for 15 min. Following incubation for 20 min at 37 °C, 0.2 ml of 0.9 M trisodium citrate were
added, and the cells were then spun down as above. The cells were
gently resuspended in 1 ml of LB medium, shaken for 3 h at
37 °C, and then centrifuged (6000 rpm for 10 min). The supernatant
was removed completely, and the cells were resuspended in 100 µl of
LB medium and plated on LB plates containing 10 µg/ml kanamycin, 50 µg/ml ampicillin, and 0.2% L-arabinose. The colonies
that appeared were streaked on LB plates containing 50 µg/ml
kanamycin, 50 µg/ml ampicillin, and 0.2% L-arabinose.
The replacement of the groEL gene by the nptII
gene was further confirmed by the ability of the cells to grow in the
presence of L-arabinose but not glucose and by PCR as
described (28). By using this methodology, we have created strains that
contain only pBADEL-encoded wild-type GroEL or one of the five
following mutants: (i) Lys-4
Glu; (ii) Arg-197
Ala; (iii)
Arg-501
Ala; (iv) Glu-409
Ala; Arg-501
Ala; and (v) Arg-13
Gly; Ala-126
Val. The source of GroES is endogenous under
control of the original GroE promoter. The strains are designated TG1
EL/pBADEL(mutant type).
Cell Growth--
Overnight cultures grown at 25 °C were
diluted 1:100 in 10 ml of LB medium containing 50 µg/ml ampicillin,
50 µg/ml kanamycin, and 0.02% arabinose in 100-ml flasks. The
temperature was shifted to 42 °C after 2.5 h. Cell density was
determined at different time intervals by measuring the optical
density at 560 nm.
Phage Infection--
TG1
EL/pBADEL cells containing only
plasmid-encoded wild-type or mutant GroEL were tested for their ability
to support the growth of phages
(b2CI), T5, and
T4(D0). The different strains were grown at 37 °C in 2 ml of LB medium containing 50 µg/ml ampicillin, 50 µg/ml kanamycin,
and 0.2% arabinose until stationary phase. Cells (300 µl) were mixed
with 3 ml of molten soft agar (0.8% Bacto-agar) at 48 °C without or
with arabinose at a final concentration of 0.2% and spread on LB
plates containing 50 µg/ml ampicillin and 50 µg/ml kanamycin to
create a lawn. 2 µl of phages
(2 × 109 pfu/ml),
T5 (4 × 1010 pfu/ml), and T4 (2 × 109 pfu/ml) were spotted onto the lawn. After overnight
incubation at 25 or 37 °C clear areas appeared in some cases
indicating phage growth.
Measurements of Bioluminescence--
The different
TG1
EL/pBADEL strains containing the lux operon of
V. fischeri were grown overnight with shaking at 30 °C in NZCYM broth containing 50 µg/ml kanamycin, 50 µg/ml ampicillin, 5 µg/ml tetracycline, and unless otherwise stated, 0.02% arabinose. The overnight cultures were then transferred to 20 or 28 °C, and growth was continued in the presence or absence of 50 ng/ml of the
synthetic autoinducer N-(3-oxyhexanoyl) homoserine lactone. At different times, 100 µl of the cultures were removed, and their luminescence was measured using a Microtox model 2055 luminometer. The
different TG1
EL/pBADEL strains were also streaked on NZCYM plates
containing the appropriate antibiotics and incubated for 20 h at
30 °C. Luminescence started to develop upon transfer to 28 °C.
GroE-assisted Reactivation of V. fischeri Luciferase
and
Subunits--
Lyophilized luciferase (Sigma) was dissolved in buffer A
containing 100 mM Hepes, 100 mM KCl, 100 mM MgCl2, and 4 mM dithiothreitol (pH 7.6). The luciferase was denatured by a 4-fold dilution with a
solution containing final concentrations of 6 M urea, 10 mM HCl, and 4 mM dithiothreitol followed by
incubation at 25 °C for 30 min. Fractions were snap-frozen and
stored at
80 °C in siliconized test-tubes. A solution (94 µl)
containing wild-type or mutant GroEL (9.1 µM) with or
without 9.1 µM GroES in buffer A with 10 mM
dithiothreitol was incubated at 25 °C for 2 min before adding it to
2 µl of 38 mg/ml unfolded luciferase that was preincubated similarly
in a siliconized test-tube. ATP at a final concentration of 20 mM was added after 5 min, and incubation at 25 °C was
continued for an additional 10 min before transfer to 18 °C.
Aliquots from the reactivation mixture were removed at different times,
and luciferase activity was measured as described (29) with some modifications. A mixture of 10 µl of 1 mg/ml FMN and 300 µl of buffer A containing 0.05% bovine serum albumin was prepared. The FMN
was reduced by adding 10 µl of 0.1 mg/ml sodium dithionite. An
aliquot of 10 µl from the reactivation mixture was then immediately added followed by rapid addition of 300 µl of 0.005% (v/v)
n-decyl aldehyde that had been freshly sonicated. The
solution was vortexed for 5 s, and luminescence was measured using
a Lumac 3M luminometer.
 |
RESULTS |
Cell Growth--
The E. coli TG1
EL/pBADEL cell
strains containing only plasmid-encoded wild-type or mutant GroEL were
tested for their ability to grow at different temperatures. No
differences in the growth of the various strains were observed at
25 °C in the presence of 0.02 or 0.2% arabinose. Upon a temperature
shift to 37 (data not shown) or 42 °C (Fig.
1), TG1
EL/pBADEL(R197A) cells were found to reach a lower yield. The TG1
EL/pBADEL strains expressing wild-type GroEL or mutants other than GroEL(R197A) were found to grow
similarly.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Effects of temperature shift from 25 to
42 °C on cell growth. TG1 EL/pBADEL strains were grown
overnight at 25 °C and diluted 1:100 in 10 ml of LB medium
containing 50 µg/ml ampicillin, 50 µg/ml kanamycin, and 0.02%
arabinose in 100-ml flasks. The temperature was shifted to 42 °C
after 2.5 h as indicated by the arrow. Cell density was
determined at different times by measuring the optical density at 560 nm.
|
|
Infection with Phages
, T4, and T5--
The six TG1
EL/pBADEL
strains containing only plasmid-encoded wild-type or mutant GroEL were
tested for their ability to support the growth of phages
(b2CI), T5, and T4(D0) under different
conditions (Table I). All six strains
were found to support the growth of phages T4 and T5 at 25 °C in the
presence of 0.002 or 0.2% arabinose which induces expression of GroEL
(25). Growth of phage
under these conditions was found to be
supported by all the strains except TG1
EL/pBADEL(R197A). All six
strains were found to support the growth of phages T4 and T5 at
37 °C in the presence of 0.2% arabinose. Support of growth of phage
is observed under these conditions in the case of
TG1
EL/pBADEL(wild-type) and all the other strains except
TG1
EL/pBADEL(R197A) (Fig. 2). All the
strains were found to support the growth of phages T4, T5, and
at
37 °C in the presence of 0.002% arabinose except the
TG1
EL/pBADEL(R197A) strain which is not viable under these
conditions (Fig. 2).
View this table:
[in this window]
[in a new window]
|
Table I
Propagation of phages T4, T5, and by the different TGI EL/pBADEL
strains under different conditions
Propagation or lack of propagation is indicated by + and ,
respectively. Strains containing the other GroEL mutants in this study
were found to propagate phages T4, T5, and like TGI EL/pBADEL
(wild type).
|
|

View larger version (138K):
[in this window]
[in a new window]
|
Fig. 2.
Support of growth of phages
, T4(D0), and T5. The
TG1 EL/pBADEL(wild-type) and TG1 EL/pBADEL(R197A) strains were
grown in the presence of 0.2% arabinose until stationary phase and
spread on LB plates with a final concentration of 0.2 or 0.002%
arabinose. 2 µl of phages (2 × 109 pfu/ml), T5
(4 × 1010 pfu/ml), and T4 (2 × 109
pfu/ml) were spotted onto the lawn. After overnight incubation at
37 °C, clear areas appeared in certain cases thus indicating phage
growth.
|
|
Effects of Mutations in GroEL on Bioluminescence--
The
different TG1
EL/pBADEL cell strains containing the full
lux operon of V. fischeri were streaked on an
NZCYM plate containing 0.02% arabinose and the appropriate antibiotics
and incubated for 20 h at 30 °C. Upon transfer to 28 °C,
luminescence started to develop with kinetics and intensity which were
found to be GroEL mutant-specific. After 2 h at 28 °C, all the
strains produced light, but the amount of light produced by the
TG1
EL/pBADEL strains expressing GroEL(R501A) and GroEL(R13G, A126V)
was found to be significantly lower (Fig.
3, left). It may be seen in
Fig. 3 that the amount of light produced is not necessarily
proportional to the cell density. TG1
EL/pBADEL(R501A), for example,
grew well but produced little light, whereas TG1
EL/pBADEL(R197A)
grew poorly but produced much more light (Fig. 3, right). In
order to investigate this issue further, we followed the development of
luminescence by each of the TG1
EL/pBADEL strains at different
temperatures and initial cell densities (Fig.
4). All the strains grew similarly during
the course of the experiments (not shown) and produced light at
20 °C at a high cell density (Fig. 4B). The maximal light production of strains containing either GroEL(R501A) or GroEL(R13G, A126V) was found to be less than that of the other strains in agreement
with results shown in Fig. 3. These two strains and also the strain
containing GroEL(E409A, R501A) did not produce any measurable light at
28 °C, whereas the strains containing GroEL(wild-type), GroEL(K4E),
or GroEL(R197A) produced light at 28 °C but less than at 20 °C.
The TG1
EL/pBADEL(R197A) strain produced light at 28 °C at a low
cell density, whereas at high cell densities it did not produce any
light (Fig. 4, C and D) in agreement with the
results shown in Fig. 3. The strains containing GroEL(wild-type),
GroEL(K4E), or GroEL(R197A) produce more light at 20 °C than the
three strains containing either GroEL(R501A), GroEL(R13G, A126V), or
GroEL(E409A, R501A) which at 28 °C do not produce any light. All the
strains were found to produce light at 28 °C if the synthetic
autoinducer was added, but the light production by the
TG1
EL/pBADEL(R501A) and TG1
EL/pBADEL(R13G, A126V) strains was
very low (data not shown).

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 3.
Luminescence at 28 °C of
TG1 EL/pBADEL cells containing the
lux operon of V. fischeri. The
different TG1 EL/pBADEL strains were streaked on a NZCYM plate
containing the appropriate antibiotics and 0.02% arabinose. The plate
was incubated at 30 °C for 20 h and then transferred to
28 °C for 1.5 h before being photographed using a Nikon model
TEA CCD-512 TKB/1 camera and a 1-s exposure in the dark
(left) or in daylight (right).
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of temperature and cell density on
the kinetics of onset of luminescence in
TG1 EL/pBADEL cells containing the
lux operon of V. fischeri.
Cultures were inoculated, diluted in a 2-fold serial manner, and grown
overnight with shaking at 30 °C in NZCYM broth containing the
appropriate antibiotics and 0.02% arabinose. Overnight cultures that
reached an optical density at 600 nm of 0.3 (±0.1) (A and
C) or 1.5 (±0.2) (B and D) were
transferred to 20 (A and B) or 28 °C
(C and D), and shaking was continued. At
different times, 100 µl of the cultures were removed, and their
luminescence was measured using a Microtox model 2055 luminometer.
|
|
Effects of Expression Level of GroEL on Luminescence--
The
development of luminescence by the TG1
EL/pBADEL strains
containing wild-type GroEL, GroEL(R197A), and GroEL(R501A) was followed at 28 °C in the presence of different concentrations of
arabinose, which induces expression of GroEL (25). In the presence of
0.01% arabinose, the TG1
EL/pBADEL(wild-type) and TG1
EL/pBADEL(R197A) strains produced light, whereas the
TG1
EL/pBADEL(R501A) strain did not (not shown). In the presence of
0.02% arabinose, only the TG1
EL/pBADEL(wild-type) strain was found
to produce light (Fig. 4D). In the presence of 0.2%
arabinose none of these three strains produced light (not shown).
Effects of Mutations in GroEL on Reactivation of Denatured V. fischeri Luciferase
and
Subunits--
Luciferase
and
subunits that had been denatured in 6 M urea and 10 mM HCl were found to fold spontaneously to a small extent
upon dilution into folding buffer (Fig.
5A). In the presence of
wild-type GroEL (Fig. 5A) or the different mutants, folding was completely arrested indicating that denatured
and/or
luciferase subunits bind tightly to GroEL. Reactivation was found to
require the full GroE system and was arrested also in the presence of GroEL and ATP except in the case of the GroEL(R13G, A126V) mutant (Fig.
5B). In the presence of wild-type GroEL, GroES, and ATP, the
yield of reactivation was increased about 4-fold relative to
spontaneous folding (Fig. 5A). The yield of reactivation by GroEL(R13G, A126V), in the presence of GroES and ATP, was about 50%
that of wild-type GroEL (Fig. 5C). The yields of
reactivation by the other mutants in the presence of GroES and ATP were
found to be similar to that of wild-type GroEL.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
GroE-assisted reactivation of V. fischeri luciferase. Unfolded and subunits of
luciferase were transferred to folding conditions in the absence of
GroEL or in the presence of either wild-type GroEL, wild-type GroEL and
ATP, or wild-type GroEL with GroES and ATP, and the recovery of enzyme
activity was measured as a function of time (A). Similar
experiments were carried out in the presence of GroEL (wild-type or the
various mutants) and ATP (B) and in the presence of GroEL
(wild-type or the various mutants), GroES, and ATP (C). The
data in C are normalized relative to wild-type GroEL.
|
|
 |
DISCUSSION |
Bacteriophage P1 transduction was used to generate E. coli TG1 strains that express only plasmid-derived wild-type GroEL
or mutants with various modified and well characterized allosteric properties. The effects of these mutations on the function of GroEL
in vivo were studied using the following two assays: (i) propagation of phages
, T4, and T5 and (ii) the bioluminescence of
cells containing the full lux operon of V. fischeri. The GroE system was first identified by genetic studies
of bacteriophage growth (30). Bacteriophages
(31, 32) and T5 (33)
employ the host GroE system for the folding of their own proteins.
Bacteriophage T4 uses host GroEL but its own co-chaperonin, Gp31, for
the folding of its major capsid protein, Gp23 (34, 35). Luminescence in V. fischeri cells and in E. coli cells that
contain the lux genes requires the product of the
luxR gene which activates transcription of the
lux operon upon binding to an autoinducer (27). The GroE system is believed to facilitate the folding in vivo of the
LuxR protein (36, 37) and possibly also the luciferase
(LuxA) and
(LuxB) subunits (38). The lux operon also contains
luxC, luxD, and luxE which code for
enzymes required for synthesis of the long chain aldehyde luciferase
substrate, luxI which codes for an enzyme involved in
autoinducer synthesis and luxG which codes for a protein
with unknown function (27).
The functional consequences in vivo of mutations that alter
the allosteric properties of GroEL are found in this study to be
protein substrate-specific. Cells containing GroEL(R197A), for example,
grow poorly at 37 (not shown) and 42 °C (Fig. 1) and do not support
growth of phage
but do support growth of phages T4 and T5 (Fig. 2)
and the folding of the lux operon gene products and other
proteins that may be required for light production (Figs. 3 and 4).
Cells containing GroEL(R501A) or GroEL(R13G, A126V), on the other hand,
support the growth of phages
, T4, and T5 (not shown) but not the
folding at 28 °C of one or more of the proteins required for
bioluminescence (Figs. 3 and 4). The need for specific allosteric
properties in GroEL therefore depends on the nature of the protein substrates.
The requirement for the GroE system for folding in vivo can
be circumvented by changing conditions in a substrate-specific manner.
All the TG1
EL/pBADEL strains examined in this study produce light at
20 °C (Fig. 4B), thus suggesting that unassisted folding of the proteins required for bioluminescence is more efficient at this
temperature as, for example, observed in the case of
ribulose-bisphosphate carboxylase/oxygenase (7). All the
TG1
EL/pBADEL strains examined in this study also produce light at
28 °C when inducer is added (not shown), perhaps because the active
conformation of LuxR is stabilized in its presence (27). Light
production by cells containing GroEL(R501A) or GroEL(R13G, A126V) at
28 °C is, however, very low in the presence of inducer.
Interestingly, the TG1
EL/pBADEL(R197A) strain which grows
poorly at 37 and 42 °C is the only one that produces relatively more
light at a low cell density, perhaps because folding of proteins which
inhibit luminescence, such as LexA (27), is not facilitated by GroEL(R197A).
The effects in vivo of mutations in GroEL are also found to
depend on its level of expression. If the GroEL mutant has low affinity
for unfolded protein substrates then increasing its concentration may
reduce the effect of the mutation in vivo. This may explain why the TG1
EL/pBADEL(R197A) strain is not viable at 37 °C when the concentration of arabinose is less than 0.002% (Fig. 2). If, however, the GroEL mutant binds unfolded proteins but does not release
them (i.e. it is a "trap" mutant), then lowering its
concentration may diminish the effect of the mutation. For example, all
the TG1
EL/pBADEL strains produce less light at 28 °C in the
presence of 0.2% arabinose than in the presence of 0.02% arabinose
(not shown). Changes in the expression level of GroEL also alter the GroEL/GroES ratio in the cell which, although physiologically important, does not affect the conclusions in this study since the
amount of GroEL in the different strains was determined to be the same
(not shown).
An understanding of how the mutations in GroEL affect its function
in vivo requires identification of the relevant substrate protein(s) whose misfolding leads to the observed phenotype and establishing the mechanism by which the mutation causes the misfolding. Here, we concentrated on trying to understand the reasons for differences in bioluminescence of the different TG1
EL/pBADEL strains
containing the lux operon. We initially focused on LuxR as the
substrate of GroEL because of reports in the literature that GroE
facilitates the folding in vivo of the LuxR protein (36,
37). GroEL was found to bind denatured LuxR and release it in an ATP-
and GroES-dependent manner, but no differences in binding
or release of LuxR by the different mutants were observed (not shown)
in agreement with the small effect of the autoinducer on light
production by the TG1
EL/pBADEL(R501A) and TG1
EL/pBADEL(R13G, A126V) strains. Next we analyzed GroE-assisted reactivation of denatured
and
luciferase subunits. The GroE system was
previously shown to facilitate the in vitro folding of
bacterial luciferase from Vibrio harveyi (38). The
extent of reactivation of
and
luciferase subunits by wild-type
GroEL and the various mutants, in the presence of GroES and ATP, was
found to be similar except in the case of GroEL(R13G, A126V) where the
yield was about 50% that of the others (Fig. 5C).
GroEL(R13G, A126V) lacks negative cooperativity between rings but has
intact intra-ring positive cooperativity and a
kcat of ATP hydrolysis similar to that of wild-type GroEL (20). This mutant was also found to differ from wild-type GroEL and the other mutants in being able to release bound
luciferase in the presence of ATP alone (Fig. 5B). It was recently shown that the ATP-bound conformation of GroEL(A126V) is
similar to the GroES-bound conformation of wild-type GroEL (39) thus
explaining why ATP by itself can trigger release of substrates bound to
GroEL(R13G, A126V). ATP-triggered release of luciferase subunits in a
conformation not yet committed to fold may contribute to the lower
yield of folding in the presence of GroEL(R13G, A126V) relative to
wild-type GroEL. The GroEL(A126V) mutant was also found to form
symmetric 2:1 GroES-GroEL complexes (39) in which substrate-binding
sites are blocked. These properties of GroEL(A126V) may explain why
cells containing GroEL(R13G, A126V) do not produce light at 28 °C.
We do not yet know which proteins required for bioluminescence fail to
fold in the presence of GroEL(R501A) and also which proteins involved
in cell growth and
phage propagation fail to fold in the presence
of GroEL(R197A) at 25 and 37 °C.
Our results suggest that mutations that perturb specific steps in the
reaction cycle of GroEL are likely to be relatively more damaging. For
example, cells containing only GroEL(D398A), which is defective in
ATP hydrolysis, are not viable (not shown), whereas cells containing
GroEL(K4E), which tends to dissociate into monomers (18, 19), exhibit a
normal phenotype. This phenotype may be due, in part, to assembly into
oligomeric structures in the presence of physiological concentrations
of ATP (data not shown). GroEL(K4E) and also minichaperones (15) may
retain some chaperoning function owing to mass action without trapping
substrate proteins.
In summary, our results indicate that allosteric communication in GroEL
is important for the in vivo folding of a subset of substrates under certain physiological conditions. The poor growth of
TG1
EL/pBADEL(R197A) at 42 °C and the formation of inclusion bodies in these cells (not shown) suggests that intact positive cooperativity may be of particular importance under stress conditions. Disrupted positive cooperativity reduces the shift in equilibrium under
stress conditions toward the protein acceptor state of GroEL. Hartl and
co-workers (40) recently identified a set of in vivo substrates of GroEL. Our results suggest that a "universal" set of
protein substrates does not exist and that the set of substrates that
interact with GroEL in vivo depends on the physiological conditions.
 |
ACKNOWLEDGEMENTS |
We thank Dr. P. Lund for phage P1, the
AI90/pBADEL strain, and helpful advice and Dr. S. van der Vies for
phages
, T4, and T5.
 |
FOOTNOTES |
*
This work was supported by the Israel Science Foundation
administered by The Israel Academy of Sciences and Humanities and the
MINERVA Foundation, Germany.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Incumbent of the Carl and Dorothy Bennett Professorial Chair
in Biochemistry. To whom correspondence should be addressed. Tel.:
972-8-9343399; Fax.: 972-8-9344188; E-mail:
Amnon.Horovitz@weizmann.ac.il.
Published, JBC Papers in Press, September 5, 2000, DOI 10.1074/jbc.M007594200
 |
ABBREVIATIONS |
The abbreviations used are:
PCR, polymerase
chain reaction;
pfu, plaque-forming units.
 |
REFERENCES |
| 1.
|
Sigler, P. B.,
Xu, Z.,
Rye, H. S.,
Burston, S. G.,
Fenton, W. A.,
and Horwich, A. L.
(1998)
Annu. Rev. Biochem.
67,
581-608
|
| 2.
|
Ellis, R. J.,
and Hartl, F.-U.
(1999)
Curr. Opin. Struct. Biol.
9,
102-110
|
| 3.
|
Ranson, N. A.,
White, H. E.,
and Saibil, H. R.
(1998)
Biochem. J.
333,
233-242
|
| 4.
|
Horovitz, A.
(1998)
Curr. Opin. Struct. Biol.
8,
93-100
|
| 5.
|
Braig, K.,
Otwinowski, Z.,
Hegde, R.,
Boisvert, D. C.,
Joachimiak, A.,
Horwich, A. L.,
and Sigler, P. B.
(1994)
Nature
371,
578-586
|
| 6.
|
Hunt, J. F.,
Weaver, A. J.,
Landry, S. J.,
Gierasch, L.,
and Deisenhofer, J.
(1996)
Nature
379,
37-45
|
| 7.
|
Viitanen, P. V.,
Lubben, T. H.,
Reed, J.,
Goloubinoff, P.,
O'Keefe, D. P.,
and Lorimer, G. H.
(1990)
Biochemistry
29,
5665-5671
|
| 8.
|
Roseman, A. M.,
Chen, S.,
White, H.,
Braig, K.,
and Saibil, H. R.
(1996)
Cell
87,
241-251
|
| 9.
|
Gray, T. E.,
and Fersht, A. R.
(1991)
FEBS Lett.
292,
254-258
|
| 10.
|
Bochkareva, E. S.,
Lissin, N. M.,
Flynn, G. C.,
Rothman, J. E.,
and Girshovich, A. S.
(1992)
J. Biol. Chem.
267,
6796-6800
|
| 11.
|
Jackson, G. S.,
Staniforth, R. A.,
Halsall, D. J.,
Atkinson, T.,
Holbrook, J. J.,
Clarke, A. R.,
and Burston, S. G.
(1993)
Biochemistry
32,
2554-2563
|
| 12.
|
Yifrach, O.,
and Horovitz, A.
(1994)
J. Mol. Biol.
243,
397-401
|
| 13.
|
Yifrach, O.,
and Horovitz, A.
(1995)
Biochemistry
34,
5303-5308
|
| 14.
|
Yifrach, O.,
and Horovitz, A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1521-1524
|
| 15.
|
Chatellier, J.,
Hill, F.,
Lund, P. A.,
and Fersht, A. R.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9861-9866
|
| 16.
|
Wang, J. D.,
Michelitsch, M. D.,
and Weissman, J. S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12163-12168
|
| 17.
|
Weber, F.,
Keppel, F.,
Georgopoulos, C.,
Hayer-Hartl, M. K.,
and Hartl, F.-U.
(1998)
Nat. Struct. Biol.
5,
977-985
|
| 18.
|
Horovitz, A.,
Bochkareva, E. S.,
and Girshovich, A. S.
(1993)
J. Biol. Chem.
268,
9957-9959
|
| 19.
|
White, Z. W.,
Fisher, K. E.,
and Eisenstein, E.
(1995)
J. Biol. Chem.
270,
20404-20409
|
| 20.
|
Aharoni, A.,
and Horovitz, A.
(1996)
J. Mol. Biol.
258,
732-735
|
| 21.
|
Aharoni, A.,
and Horovitz, A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1698-1702
|
| 22.
|
Fenton, W. A.,
Kashi, Y.,
Furtak, K.,
and Horwich, A. L.
(1994)
Nature
371,
614-619
|
| 23.
|
Inbar, E.,
and Horovitz, A.
(1997)
Biochemistry
36,
12276-12281
|
| 24.
|
Horovitz, A.,
Bochkareva, E. S.,
Kovalenko, O.,
and Girshovich, A. S.
(1993)
J. Mol. Biol.
231,
58-64
|
| 25.
|
Guzman, L.-M.,
Belin, D.,
Carson, M. J.,
and Beckwith, J.
(1995)
J. Bacteriol.
177,
4121-4130
|
| 26.
|
Ulitzur, S.,
Siiman, M.,
and Kuhn, J.
(1987)
in
Bioluminescence and Chemiluminescence: New Perspectives
(Schölmerich, J.
, Andreesen, R.
, Kapp, A.
, Ernst, M.
, and Woods, W. G., eds)
, pp. 381-384, John Wiley & Sons Ltd., Chichester, UK
|
| 27.
|
Ulitzur, S.,
and Dunlap, P. V.
(1995)
Photochem. Photobiol.
62,
625-632
|
| 28.
|
Ivic, A.,
Olden, D.,
Wallington, E. J.,
and Lund, P. A.
(1997)
Gene (Amst.)
194,
1-8
|
| 29.
|
Meighen, E. A.,
and Hastings, J. W.
(1971)
J. Biol. Chem.
246,
7666-7674
|
| 30.
|
Georgopoulos, C.
(1992)
Trends Biochem. Sci.
17,
295-299
|
| 31.
|
Sternberg, N.
(1973)
J. Mol. Biol.
76,
25-44
|
| 32.
|
Georgopoulos, C. P.,
Hendrix, R. W.,
Casjens, S. R.,
and Kaiser, A. D.
(1973)
J. Mol. Biol.
76,
45-60
|
| 33.
|
Zweig, M.,
and Cummings, D. J.
(1973)
J. Mol. Biol.
80,
505-518
|
| 34.
|
Laemmli, U. K.,
Beguin, F.,
and Gujer-Kellenberger, G.
(1970)
J. Mol. Biol.
47,
69-85
|
| 35.
|
van der Vies, S. M.,
Gatenby, A. A.,
and Georgopoulos, C.
(1994)
Nature
368,
654-656
|
| 36.
|
Dolan, K. M.,
and Greenberg, E. P.
(1992)
J. Bacteriol.
174,
5132-5135
|
| 37.
|
Adar, Y. Y.,
and Ulitzur, S.
(1993)
J. Biolumin. Chemilumin.
8,
261-266
|
| 38.
|
Fedorov, A. N.,
and Baldwin, T. O.
(1997)
J. Mol. Biol.
268,
712-723
|
| 39.
|
Llorca, O.,
Perez-Perez, J.,
Carrascosa, J. L.,
Galan, A.,
Muga, A.,
and Valpuesta, J. M.
(1997)
J. Biol. Chem.
272,
32925-32932
|
| 40.
|
Houry, W. A.,
Frishman, D.,
Eckerskorn, C.,
Lottspeich, F.,
and Hartl, F.-U.
(1999)
Nature
402,
147-154
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Miyazaki, T. Yoshimi, Y. Furutsu, K. Hongo, T. Mizobata, M. Kanemori, and Y. Kawata
GroEL-Substrate-GroES Ternary Complexes Are an Important Transient Intermediate of the Chaperonin Cycle
J. Biol. Chem.,
December 20, 2002;
277(52):
50621 - 50628.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.